 |
 |
|
|
|
| Triptorelin Acetate |
 |
| Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2 |
 |
| 57773-63-4 (net) |
 |
For the treatment of advanced hormone-dependent prostate cancer endometriosis and central precocious puberty.
Use in reproduction medicine.
|
 |
| Triptorelin acetate is a potent LHRH agonist. After a transient increase, continuous administration results in down-regulation of LH and FSH levels followed by a suppression of ovarian and testicular steroid biosynthesis. |
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
